Indeed, Gal-1-induced radiation resistance has been overcome by using the Gal-1-targeting, designed peptide inhibitor anginex in multiple human and syngeneic murine tumor models [108,136,137,138,169]. The gene discussed is GAL; the disease is neoplasm.